Skip to main content

CORRECTION article

Front. Oncol., 14 February 2023
Sec. Hematologic Malignancies
Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.1132485

This article is a correction to:

  1. Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

    1. Read original article
Huijuan Zhao,Huijuan Zhao1,2Ziqing WeiZiqing Wei3Guomin Shen,Guomin Shen1,2Yixiang Chen,Yixiang Chen1,2Xueqin Hao*Xueqin Hao2*Sanqiang Li*Sanqiang Li2*Rong Wang*Rong Wang4*
  • 1Henan International Joint Laboratory of Thrombosis and Hemostasis, Henan University of Science and Technology, Luoyang, China
  • 2Basic Medical College, Henan University of Science and Technology, Luoyang, China
  • 3Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China
  • 4Department of Clinical Laboratory, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, China

A corrigendum on
Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy

by Zhao H, Wei Z, Shen G, Chen Y, Hao X, Li S and Wang R (2022).  12:1045797. doi: 10.3389/fonc.2022.1045797

Incorrect Affiliation

In the published article, there was an error in affiliations 1 and 2. Instead of “1Basic Medical College, Henan University of Science and Technology, Luoyang, China, 2Henan International Joint Laboratory of Thrombosis and Hemostasis, Henan University of Science and Technology, Luoyang, China”, it should be “1Henan International Joint Laboratory of Thrombosis and Hemostasis, Henan University of Science and Technology, Luoyang, China, 2Basic Medical College, Henan University of Science and Technology, Luoyang, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: poly(rC)-binding proteins, hematopoiesis, hematological malignancy, mRNA stability, alternative splicing

Citation: Zhao H, Wei Z, Shen G, Chen Y, Hao X, Li S and Wang R (2023) Corrigendum: Poly(rC)-binding proteins as pleiotropic regulators in hematopoiesis and hematological malignancy. Front. Oncol. 12:1132485. doi: 10.3389/fonc.2022.1132485

Received: 27 December 2022; Accepted: 30 December 2022;
Published: 14 February 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Zhao, Wei, Shen, Chen, Hao, Li and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xueqin Hao, aGFveHVlcWluQGhhdXN0LmVkdS5jbg==; Sanqiang Li, c2FucWlhbmdsaTIwMDFAMTYzLmNvbQ==; Rong Wang, d2FuZ3JvbmczNjYwMjAxMEAxNjMuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.